Guangdong Taiantang Pharmaceutical Co.Ltd(002433) : independent opinions of independent directors on matters related to the 10th meeting of the Fifth Board of directors of the company

Guangdong Taiantang Pharmaceutical Co.Ltd(002433) independent director

Independent opinions on matters related to the 32nd meeting of the Fifth Board of directors of the company. In accordance with the company law of the people’s Republic of China, the guidelines for the standardized operation of listed companies of Shenzhen Stock Exchange, the articles of association, the working system of independent directors and other relevant provisions, we are the independent directors of Guangdong Taiantang Pharmaceutical Co.Ltd(002433) (hereinafter referred to as ” Guangdong Taiantang Pharmaceutical Co.Ltd(002433) ” or “the company”), We hereby express our independent opinions on the relevant matters considered at the 32nd meeting of the Fifth Board of directors of the company as follows:

The company provides guarantee for kangaido, which is conducive to the operation and development of kangaido. When the above guarantee matters are considered at the meeting of the board of directors of the company, the related directors have avoided voting according to law, the decision-making procedures comply with the provisions of relevant laws and regulations and the articles of Association, and there is no behavior damaging the interests of the company, especially the minority shareholders. We agree that the company provides the above guarantee for kangaido and agree to submit the guarantee to the general meeting of shareholders of the company for deliberation. (there is no text on the next page, which is the signature page of the independent directors’ independent opinions on matters related to the 32nd meeting of the Fifth Board of directors of the company)

(there is no text on this page, which is the signature page of independent directors’ independent opinions on matters related to the 32nd meeting of the Fifth Board of directors of the company) signature of independent directors:

Wang Guihua, Nie Zhijin, Liu Li

February 15, 2002

- Advertisment -